Illumina collaboration update due24 Apr 2023 17:11
"We are delighted to announce the successful operational launch of the Verici Dx data analysis processing and predictive artificial intelligence components of our clinical products as inaugural users of Illumina's new ICA platform," said chief executive officer Sara Barrington.
"Our leading-edge science depends on the ability to process vast amounts of data into meaningful and interpretable segments, and we believe there is no better tool to support us in this than ICA.
"We are very proud to be an early-access user of this tool in the commercial space from a world-class provider and leader in servicing the global sequencing market."
Barrington said the milestone represented a "key step" in the readiness of both the near-term launches of Verici's flagship 'Clarava' and 'Tuteva' products, as well as the long-term strategy for building the computational data analytics tools that would power Verici's data science.
"We look forward to updating the market with our further progress towards commercialization in due course."